Follicopeptide

For healthy hair growth.
Planned launch in the end of 2025.

NPP-4

For natural skin pigmentation.
Planned launch in 2026.

To lead the future of hair and skin longevity

Coegin Pharma is a Swedish biotechnology company developing cutting-edge innovations for hair growth and skin pigmentation. We plan to launch a hair growth product line by the end of 2025, followed by a skin pigmentation product in 2026.

Read more about us

Latest news

Press releases

More press releases

Reports

More reports

Upcoming events

More events

Get our press releases, company updates and financial reports straight to your inbox.

Subscribe

Receive press releases and reports to your e-mail.

Team Coegin

Jens Eriksson
Jens Eriksson
Chief Executive Officer
Lars Bukhave Rasmussen
Lars Bukhave Rasmussen
Chief Financial Officer
John Zibert
John Zibert
Chief Scientific Officer